Literature DB >> 12924491

Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome.

Shinji Teramoto1, Haruki Kume, Hiroshi Yamamoto, Takeo Ishii, Akira Miyashita, Takeshi Matsuse, Masahiro Akishita, Kenji Toba, Yasuyoshi Ouchi.   

Abstract

OBJECTIVE: Repeated nocturnal hypoxia is implicated in the pathogenesis of cardiovascular complications in obstructive sleep apnea syndrome (OSAS). We hypothesized that circulating vascular endothelial growth factor (VEGF) levels are affected by nocturnal hypoxemia in patients with OSAS.
METHODS: We examined the serum VEGF levels in patients with OSAS and in control subjects. We also tested the effects of oxygen or air administration on the subjects' VEGF levels. PATIENTS AND MATERIALS: Twenty-four OSAS patients (mean age 54.2 +/- 3.6 years) and 24 age-matched control subjects (53.2 +/- 3.6 years). Their serum samples were tested.
RESULTS: Serum VEGF levels at 8:00 AM were significantly higher in OSAS patients than in controls (p<0.01). VEGF levels decreased from 515 +/- 31 (pg/ml) to 178 +/- 16 (pg/m) (p<0.01) in OSAS patients whose nocturnal hypoxemia was found to be improved by administration of 2 l/min of oxygen during the night. However, the administration of compressed air affected neither the VEGF level nor nocturnal oxygen desaturation in OSAS patients.
CONCLUSION: These results indicate that circulating VEGF levels are elevated in OSAS patients, primarily due to nocturnal hypoxemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12924491     DOI: 10.2169/internalmedicine.42.681

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  13 in total

1.  Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP.

Authors:  Anne Briançon-Marjollet; Marion Henri; Jean-Louis Pépin; Emeline Lemarié; Patrick Lévy; Renaud Tamisier
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

2.  Vascular endothelial growth factor levels in patients with obstructive sleep apnea: a meta-analysis.

Authors:  Xiao-Bin Zhang; Xing-Tang Jiang; Fang-Rong Cai; Hui-Qing Zeng; Yan-Ping Du
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-28       Impact factor: 2.503

Review 3.  Impact of continuous positive airway pressure on vascular endothelial growth factor in patients with obstructive sleep apnea: a meta-analysis.

Authors:  Jia-Chao Qi; LiangJi Zhang; Hao Li; Huixue Zeng; Yuming Ye; Tiezhu Wang; Qiyin Wu; Lida Chen; Qiaozhen Xu; Yifeng Zheng; Yaping Huang; Li Lin
Journal:  Sleep Breath       Date:  2018-04-18       Impact factor: 2.816

4.  Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome.

Authors:  Jing Ma; Yongjian Xu; Zhenxiang Zhang; Huiguo Liu; Weining Xiong; Shuyun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

5.  Obstructive sleep apnea: Is it a biomarker of metabolic health in obesity.

Authors:  Nancy L Mora Becerra; Bradley Needleman; Sabrena Noria; David Bradley
Journal:  Obes Med       Date:  2017-04-10

6.  Consequences of hypoxia-reoxygenation phenomena in patients with obstructive sleep apnea syndrome.

Authors:  Tansu Ulukavak Ciftci; Oguz Kokturk; Senay Demirtas; Ozlem Gulbahar; Neslihan Bukan
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

Review 7.  Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Panagoula Kollia; Konstantinos I Gourgoulianis
Journal:  Respir Res       Date:  2006-10-17

8.  Novel biochemical markers of psychosocial stress in women.

Authors:  Marie Asberg; Ake Nygren; Rosario Leopardi; Gunnar Rylander; Ulla Peterson; Lukas Wilczek; Håkan Källmén; Mirjam Ekstedt; Torbjörn Akerstedt; Mats Lekander; Rolf Ekman
Journal:  PLoS One       Date:  2009-01-29       Impact factor: 3.240

9.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27

10.  The evaluation of retinal nerve fiber layer thickness in patients with obstructive sleep apnea syndrome.

Authors:  Mehmet Adam; Mehmet Okka; Sebnem Yosunkaya; Banu Bozkurt; Hürkan Kerimoğlu; Meydan Turan
Journal:  J Ophthalmol       Date:  2013-11-27       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.